Search arXivSearch

EXPLORE THE ARCHIVE

Samuel D. Relton

Publications and source records attributed to Samuel D. Relton.

2 recordsLinked to original sources

Scalable Clinical Data Infrastructure and Comparative ML Evaluation for Hospitalisation Risk Prediction in Elderly Patients with Multiple Long-Term Conditions using CPRD

Deep learning architectures are increasingly proposed for patient trajectory modeling in electronic health records (EHRs), yet their advantage over simpler, more interpretable models is rarely subjected to rigorous empirical scrutiny in real-world clinical settings. We present a comprehensive patient timeline pipeline applied to elderly patients in CPRD Aurum, incorporating 260 clinical conditions classified via a three-tier automated framework including specialised detection logic for 17 complex conditions. Using this infrastructure, we benchmark Temporal Graph Convolutional Neural Networks (TG-CNN) against Logistic Regression with LASSO regularisation and Random Forests for predicting 12-month all-cause emergency hospitalisation risk, motivated by (but not filtered to) the elevated risk of adverse drug reactions. Under cross-validation, TG-CNN achieves a marginally higher mean AUC-ROC than LASSO (0.712 vs. 0.705), whereas on the held-out test set LASSO achieves the highest discrimination of three models (AUC-ROC 0.733, versus 0.710 for Random Forest and 0.702 for TG-CNN). We show, that discrimination alone is an incomplete criterion for clinical deployment: after Platt calibration, LASSO is the only model with an acceptable calibration slope (0.817), while Random Forest (0.759) and, TG-CNN (0.391) remain substantially miscalibrated. We argue that LASSO, not the highest-discriminating model, is the model best suited to direct clinical deployment. We present lessons for the machine learning and healthcare community regarding data infrastructure, model selection, and value of calibration and interpretability in high-stakes decision support.

cs.LG

Variational Autoencoders for Feature Exploration and Malignancy Prediction of Lung Lesions

Lung cancer is responsible for 21% of cancer deaths in the UK and five-year survival rates are heavily influenced by the stage the cancer was identified at. Recent studies have demonstrated the capability of AI methods for accurate and early diagnosis of lung cancer from routine scans. However, this evidence has not translated into clinical practice with one barrier being a lack of interpretable models. This study investigates the application Variational Autoencoders (VAEs), a type of generative AI model, to lung cancer lesions. Proposed models were trained on lesions extracted from 3D CT scans in the LIDC-IDRI public dataset. Latent vector representations of 2D slices produced by the VAEs were explored through clustering to justify their quality and used in an MLP classifier model for lung cancer diagnosis, the best model achieved state-of-the-art metrics of AUC 0.98 and 93.1% accuracy. Cluster analysis shows the VAE latent space separates the dataset of malignant and benign lesions based on meaningful feature components including tumour size, shape, patient and malignancy class. We also include a comparative analysis of the standard Gaussian VAE (GVAE) and the more recent Dirichlet VAE (DirVAE), which replaces the prior with a Dirichlet distribution to encourage a more explainable latent space with disentangled feature representation. Finally, we demonstrate the potential for latent space traversals corresponding to clinically meaningful feature changes.

cs.CV